SNCA Gene PARK1 Parkinson Genetic Test
At DNA Labs UAE, we offer the SNCA Gene PARK1 Parkinson Genetic Test. This test is designed to analyze the DNA sequence of the SNCA gene and look for any mutations or variations that may be associated with an increased risk of developing Parkinson’s disease.
Test Details
The SNCA gene is associated with Parkinson’s disease and is one of the genes that can be tested for in a Next-Generation Sequencing (NGS) genetic test for PARK1 Parkinson’s disease. PARK1 Parkinson’s disease is a rare form of the disease that is caused by mutations in the SNCA gene.
This gene provides instructions for making a protein called alpha-synuclein, which is found in the brain and is involved in the regulation of dopamine, a neurotransmitter that is important for movement control. Mutations in the SNCA gene can lead to the accumulation of abnormal alpha-synuclein protein in the brain, which can cause the death of dopamine-producing cells and the development of Parkinson’s disease symptoms.
Test Components and Price
The SNCA Gene PARK1 Parkinson Genetic Test is priced at 4400.0 AED. The test can be performed using a blood sample, extracted DNA, or one drop of blood on an FTA Card.
Report Delivery and Method
The report for the SNCA Gene PARK1 Parkinson Genetic Test is typically delivered within 3 to 4 weeks. The test is conducted using NGS (Next-Generation Sequencing) technology, which allows for a comprehensive analysis of the SNCA gene.
Test Type and Doctor
The SNCA Gene PARK1 Parkinson Genetic Test falls under the category of Neurological Disorders. It is typically ordered by a Neurologist and performed in the Genetics department.
Pre Test Information
Before undergoing the SNCA Gene PARK1 Parkinson Genetic Test, it is important to provide the clinical history of the patient. Additionally, a Genetic Counselling session may be conducted to draw a pedigree chart of family members affected by SNCA Gene PARK1 Parkinson.
Importance of Genetic Testing
NGS genetic testing for PARK1 Parkinson’s disease can help identify individuals who may be at an increased risk of developing the condition due to mutations in the SNCA gene. This information can be useful for early detection, diagnosis, and potentially for personalized treatment and management strategies.
However, it is important to note that not all individuals with mutations in the SNCA gene will develop Parkinson’s disease, as other genetic and environmental factors also play a role in the development of the condition. Genetic testing should be done in consultation with a healthcare professional who can provide appropriate counseling and interpretation of the results.
| Test Name | SNCA Gene PARK1 Parkinson Genetic Test |
|---|---|
| Components | |
| Price | 4400.0 AED |
| Sample Condition | Blood or Extracted DNA or One drop Blood on FTA Card o |
| Report Delivery | 3 to 4 Weeks |
| Method | NGS Technology |
| Test type | Neurological Disorders |
| Doctor | Neurologist |
| Test Department: | Genetics |
| Pre Test Information | Clinical History of Patient who is going for SNCA Gene PARK1 Parkinson NGS Genetic DNA Test A Genetic Counselling session to draw a pedigree chart of family members affected with SNCA Gene PARK1 Parkinson |
| Test Details |
The SNCA gene is associated with Parkinson’s disease and is one of the genes that can be tested for in a Next-Generation Sequencing (NGS) genetic test for PARK1 Parkinson’s disease. This test analyzes the DNA sequence of the SNCA gene to look for any mutations or variations that may be associated with an increased risk of developing Parkinson’s disease. PARK1 Parkinson’s disease is a rare form of the disease that is caused by mutations in the SNCA gene. This gene provides instructions for making a protein called alpha-synuclein, which is found in the brain and is involved in the regulation of dopamine, a neurotransmitter that is important for movement control. Mutations in the SNCA gene can lead to the accumulation of abnormal alpha-synuclein protein in the brain, which can cause the death of dopamine-producing cells and the development of Parkinson’s disease symptoms. NGS genetic testing for PARK1 Parkinson’s disease can help identify individuals who may be at an increased risk of developing the condition due to mutations in the SNCA gene. This information can be useful for early detection, diagnosis, and potentially for personalized treatment and management strategies. However, it is important to note that not all individuals with mutations in the SNCA gene will develop Parkinson’s disease, as other genetic and environmental factors also play a role in the development of the condition. Genetic testing should be done in consultation with a healthcare professional who can provide appropriate counseling and interpretation of the results. |
